Templado, Baby Boy .
HRN: 23-17-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/21/2023
06/27/2023
IVTT
47mg
Q24h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes